3M Health Care announced the launch of a new Medical Diagnostics business unit that will focus on developing and commercializing rapid diagnostic product solutions for the detection of key infectious pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and other treatment-resistant microbes.
Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) to market Tamiflu (oseltamivir phosphate) capsules in pediatric doses of 30 mg and 45 mg. Tamiflu, which is indicated for the prevention and treatment of influenza types A and B in patients one year and older, is currently available in a 75 mg capsule for adults as well as liquid suspension formulation for children.
The Ministry of Health in Lao People’s Democratic Republic has confirmed the country’s first death from H5N1 avian influenza.
UC Irvine researchers have combined genetic and geographic data of the H5N1 avian flu virus to reconstruct its history over the past decade. They found that multiple strains of the virus originated in the Chinese province of Guangdong, and they identified many of the migration routes through which the strains spread regionally and internationally.
GlaxoSmithKline (GSK) announces clinical trial data from two new studies, which show, for the first time, that GSK?s candidate pre-pandemic split antigen H5N1 vaccine, formulated with GSK?s proprietary adjuvant system, provides a substantial level of cross-immunity against a ?drifted? (diverse) strain of H5N1.
A woman who fell ill last month is probably the second human victim of bird flu in Laos, although conclusive test results are still pending, a Health Ministry official said on sunday, reported by Times of India.
The Hong Kong Centre for Health Protection (CHP) of the Department of Health received notification from the Ministry of Health concerning a confirmed human case of avian influenza H5N1 in Fujian.
A comparison of the 1918 Spanish influenza and the H5N1 avian influenza viruses suggests that while the two viruses appear to trigger a similar abnormal immune response in animal models, there are distinct differences.
Scientists and public health officials, wary that the H5N1 avian influenza virus could trigger an influenza pandemic, have looked to past pandemics, including the 1918 “Spanish Flu,” for insight into pandemic planning.
A U.S. advisory panel of Food and Drug Administration has supported the bird flu vaccine data from Sanofi-Aventis pharmaceutical company.